An anonymous director reports

MEDIPHARM LABS SETS DATE TO REPORT FULL YEAR AND FOURTH QUARTER 2023 FINANCIAL RESULTS

Medipharm Labs Corp. will release its full-year and fourth quarter financial results for the period ended Dec. 31, 2023, before markets open on Wednesday, March 27, 2024.

Medipharm Labs executive management team will also host a conference call and audio webcast on Wednesday, March 27, 2024, at 8:30 a.m. Eastern Time to discuss the company's financial results.

Audio conference call dial-in details

Toll-free number: 1-888-330-2379

International number: 1-240-789-2710

Conference ID: 4921762

Participants are asked to dial in approximately 15 minutes before the start of the call.

Audio webcast

An audio webcast will be available on-line.

For those who are unable to participate on the live conference call or webcast, a replay will be available on the Medipharm website approximately one day after completion of the call.

About Medipharm Labs Corp.

Founded in 2015, Medipharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a good-manufacturing-practices-certified facility with ISO standard-built clean rooms. Medipharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. Medipharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets.

We seek Safe Harbor.